Developing better imaging and treatment methods for prostate and breast cancer
Official title: BLRD Research Career Scientist Award Application
Funded at Harry S. Truman Memorial VA Hospital · NIH-11049450 · Data updated 2026-11-12
This study is working on new ways to help doctors find and treat prostate and breast cancer earlier and more effectively, using special tools to create better medicines that could lead to improved care for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Harry S. Truman Memorial VA Hospital NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project start | October 1, 2024 |
| Project end | September 30, 2029 |
| Funding year | 2025 |
| NIH project number | 1IK6BX006810-01 |
| Project ID | NIH-11049450 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with prostate or breast cancer who are seeking advanced treatment options.
✕Less likely to help
Patients with cancers other than prostate or breast cancer may not receive direct benefits from this research.
What this research studies
This research focuses on creating improved radiopharmaceuticals that can help in the early diagnosis and treatment of prostate and breast cancer. The approach involves using advanced technologies, such as phage display, to identify new cell-targeting probes that enhance the effectiveness of these radiopharmaceuticals. Patients may benefit from more accurate diagnoses and targeted therapies that could lead to better treatment outcomes. The research is conducted at the Harry S. Truman Memorial Veterans’ Hospital, where a team of experts collaborates on these innovative projects.
Why it matters
Potential benefit: If successful, this research could lead to more effective and targeted treatments for prostate and breast cancer patients.
How similar studies have gone: Previous research in the development of targeted radiopharmaceuticals has shown promising results, indicating a potential for success in this area.
Where this research is happening
-
Harry S. Truman Memorial VA Hospital
Columbia, United States Active
Researchers
- Principal investigator: Smith, Charles J — Harry S. Truman Memorial VA Hospital
- Study coordinator: Smith, Charles J
Related research
Other NIH-funded projects on the same topics.
-
Targeted gene therapy and nanomedicine for corneal healing
A patient-facing overview of a project aiming to use gene therapy and tiny nanoparticles to treat scarring in the cornea and restore vision.
-
Sleep problems after stroke
Researchers are developing models to understand why people have sleep problems after a stroke so future treatments can help recovery.
-
How a protein called Olfm2 affects artery plaque and cholesterol handling
Researchers are looking at whether lowering a protein named Olfm2 can reduce artery plaque and improve cholesterol balance for people at risk of heart attack and stroke.
-
Liver eNOS and its role in fatty liver disease (NASH)
Researchers are looking at whether changing levels of a liver enzyme called eNOS can reduce harmful fat buildup and inflammation in adults with NASH.
-
RECK protein's role in harmful heart remodeling and heart failure
They are looking at whether boosting a protein called RECK can stop or reverse harmful heart changes that lead to heart failure in older people with pressure-related problems like high blood pressure or aortic valve narrowing.
-
Investigating vision loss from traumatic eye and brain injuries in veterans
This study is looking at how eye and brain injuries can cause vision problems, especially for veterans and active military members, and aims to create new treatments to help improve their healing and quality of life.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.